Impact and Visibility - This is Respiratory Drug Delivery
With a 35+ year track record of bringing the pulmonary and nasal drug delivery communities together, the RDD conference series continues to be recognized as a leading international meeting devoted to disseminating quality science, educating emerging thought leaders, building productive relationships, and advocating sensible regulatory policies.
The success of RDD 2026 and its predecessors is founded on the selection of internationally renowned speakers, active participation by large numbers of delegates, and strong financial support from companies active in inhalation science. By supporting RDD 2026, you build recognition in the global inhalation community and demonstrate your organization's commitment to advancing respiratory health.